Literature DB >> 31977050

Staging for Melanoma - Toward a New Paradigm?

David E Elder1, Giorgos Karakousis1, Richard A Scolyer2.   

Abstract

Entities:  

Year:  2020        PMID： 31977050      PMCID： PMC7492757          DOI： 10.1093/jnci/djaa009

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

Review 1.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

2.  Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system.

Authors:  Lauren E Haydu; John F Thompson; Richard A Scolyer; Jeffrey E Gershenwald
Journal:  Eur J Cancer       Date:  2019-03-15       Impact factor: 9.162

3.  Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer
Journal:  Ann Surg Oncol       Date:  2018-05-30       Impact factor: 5.344

4.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

5.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

6.  Reporting recommendations for tumor marker prognostic studies (REMARK).

Authors:  Lisa M McShane; Douglas G Altman; Willi Sauerbrei; Sheila E Taube; Massimo Gion; Gary M Clark
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

7.  Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.

Authors:  Phyllis A Gimotty; David E Elder; Douglas L Fraker; Jeffrey Botbyl; Kimberly Sellers; Rosalie Elenitsas; Michael E Ming; Lynn Schuchter; Francis R Spitz; Brian J Czerniecki; DuPont Guerry
Journal:  J Clin Oncol       Date:  2007-03-20       Impact factor: 44.544

8.  Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.

Authors:  Serigne N Lo; Richard A Scolyer; John F Thompson
Journal:  Ann Surg Oncol       Date:  2018-01-12       Impact factor: 5.344

9.  Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.

Authors:  Shirin Bajaj; Douglas Donnelly; Melissa Call; Paul Johannet; Una Moran; David Polsky; Richard Shapiro; Russell Berman; Anna Pavlick; Jeffrey Weber; Judy Zhong; Iman Osman
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

10.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702
  10 in total
  1 in total

1.  18 F-FDG positron emission tomography-computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high-risk Stages IIB, IIC, and IIIA melanoma.

Authors:  Zachary J Jaeger; Gregory A Williams; Ling Chen; Joyce C Mhlanga; Lynn A Cornelius; Ryan C Fields
Journal:  J Surg Oncol       Date:  2021-11-06       Impact factor: 3.454
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.